CYLD: a tumor suppressor deubiquitinase regulating NF-κB activation and diverse biological processes
Open Access
- 17 April 2009
- journal article
- review article
- Published by Springer Science and Business Media LLC in Cell Death & Differentiation
- Vol. 17 (1), 25-34
- https://doi.org/10.1038/cdd.2009.43
Abstract
Protein ubiquitination is a reversible reaction, in which the ubiquitin chains are deconjugated by a family of deubiquitinases (DUBs). The presence of a large number of DUBs suggests that they likely possess certain levels of substrate selectivity and functional specificity. Indeed, recent studies show that a tumor suppressor DUB, cylindromatosis (CYLD), has a predominant role in the regulation of NF-κB, a transcription factor that promotes cell survival and oncogenesis. NF-κB activation involves attachment of K63-linked ubiquitin chains to its upstream signaling factors, which is thought to facilitate protein–protein interactions in the assembly of signaling complexes. By deconjugating these K63-linked ubiquitin chains, CYLD negatively regulates NF-κB activation, which may contribute to its tumor suppressor function. CYLD also regulates diverse physiological processes, ranging from immune response and inflammation to cell cycle progression, spermatogenesis, and osteoclastogenesis. Interestingly, CYLD itself is subject to different mechanisms of regulation.Keywords
This publication has 90 references indexed in Scilit:
- Inactivation of the CYLD Deubiquitinase by HPV E6 Mediates Hypoxia-Induced NF-κB ActivationCancer Cell, 2008
- The tumour suppressor CYLD is a negative regulator of RIG‐I‐mediated antiviral responseEMBO Reports, 2008
- Gene mapping and expression analysis of 16q loss of heterozygosity identifies WWOX and CYLD as being important in determining clinical outcome in multiple myelomaPublished by American Society of Hematology ,2007
- Frequent Engagement of the Classical and Alternative NF-κB Pathways by Diverse Genetic Abnormalities in Multiple MyelomaCancer Cell, 2007
- Ubiquitination of RIP Is Required for Tumor Necrosis Factor α-induced NF-κB ActivationJournal of Biological Chemistry, 2006
- Regulation of T cell development by the deubiquitinating enzyme CYLDNature Immunology, 2006
- Regulation of the Deubiquitinating Enzyme CYLD by IκB Kinase Gamma-Dependent PhosphorylationMolecular and Cellular Biology, 2005
- Negative Regulation of JNK Signaling by the Tumor Suppressor CYLDJournal of Biological Chemistry, 2004
- The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responsesNature Immunology, 2004
- Spiradenocylindroma of the KidneyThe American Journal of Surgical Pathology, 2002